• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DSM BIOMEDICAL MESO BIOMATRIX ACELLULAR PERITONEUM MATRIX; MESH, SURGICAL, COLLAGEN, PLASTIC AND RECONSTRUCTIVE SURGERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DSM BIOMEDICAL MESO BIOMATRIX ACELLULAR PERITONEUM MATRIX; MESH, SURGICAL, COLLAGEN, PLASTIC AND RECONSTRUCTIVE SURGERY Back to Search Results
Model Number 30055-06
Device Problem Insufficient Information (3190)
Patient Problems Wound Dehiscence (1154); Unspecified Infection (1930); Tissue Damage (2104)
Event Date 12/04/2015
Event Type  Injury  
Manufacturer Narrative
Review of the device history records does not have deviations that would contribute to the reported complications.The product met all pre-determined acceptance criteria.Review of sterilization records indicate the product was processed in accordance with product requirements and met all pre-determined acceptance criteria for sterility.The cause of the complication can not be determined from the provided information or the manufacturing records.Device discarded at hospital.
 
Event Description
A female patient had bilateral mastectomy followed by immediate single stage, bilateral breast reconstruction with 320cc textured, silicone gel breast implants.Meso biomatrix was implanted in each breast.Approximately 2 months later, the left breast was observed to have 'thin skin.' she was started on intravenous antibiotics and the thin skin was excised and closed.On the following day, the wound was reportedly healing.However, 4 days later, the left breast wound dehisced and the implant was visible.The right breast also had an infected appearance.The patient decided to have both implants removed.So that same day, the implants and meso biomatrix were removed bilaterally.At the time of explantation, the surgeon noted the meso biomatrix to be thin and barely recognizable.Intravenous antibiotics were continued for 24 hours, followed by oral antibiotics for 5 days.The dehiscence were reported to have resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MESO BIOMATRIX ACELLULAR PERITONEUM MATRIX
Type of Device
MESH, SURGICAL, COLLAGEN, PLASTIC AND RECONSTRUCTIVE SURGERY
Manufacturer (Section D)
DSM BIOMEDICAL
735 pennsylvania drive
exton PA 19341
Manufacturer Contact
forde hansell
735 pennsylvania drive
exton, PA 19341
4847132152
MDR Report Key5470915
MDR Text Key39416367
Report Number2530154-2016-00002
Device Sequence Number1
Product Code OXH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K094061
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 03/01/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/01/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date10/31/2015
Device Model Number30055-06
Device Lot NumberC0767
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/03/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/28/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age30 YR
-
-